Class / Patent application number | Description | Number of patent applications / Date published |
424203100 | Combination of antigens from multiple bacterial species (e.g., multivalent bacterial vaccine, etc.) | 34 |
20080213305 | Vaccine for periodontitis and methods of use - The present invention is directed to an immunogenic composition for inducing an immune response against lysine decarboxylase for treating or preventing periodontitis in a subject. The present invention is also directed to methods for inducing an immunogenic response in a subject by administering such immunogenic composition. | 09-04-2008 |
20080286303 | Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease - A multi-component immunogenic composition confers protection on an immunized host against infection caused by | 11-20-2008 |
20090181050 | Manufacturing Method of Combined Vaccine - The present invention relates to a method for manufacturing a combined vaccine capable of concurrently preventing multiple diseases such as diphtheria, tetanus, pertussis, and hepatitis B which should be prevented in an infant. The method for manufacturing a combined vaccine according to the present invention includes the steps of independently adsorbing each protective antigen to an adsorbent of a aluminum hydroxide gel with respect to various diseases such as diphtheria, tetanus, pertussis, and hepatitis B which should be prevented in the infants, and combining each protective antigen adsorbed to the adsorbent after the adsorption. In the present invention, it is possible to concurrently prevent multiple diseases such as diphtheria, tetanus, pertussis, and hepatitis B which should be prevented in the infant using a combined vaccine manufactured according to the present invention. | 07-16-2009 |
20090246224 | VACCINE - The present invention relates to the field of neisserial vaccine compositions, their manufacture, and the use of such compositions in medicine. More particularly it relates to processes of making novel engineered meningococcal strains which are more suitable for the production of neisserial, in particular meningococcal, outer-membrane vesicle (or bleb) vaccines. Advantageous processes and vaccine products are also described based on the use of novel LOS subunit or meningococcal outer-membrane vesicle (or bleb) vaccines which have been rendered safer and more effective for use in human subjects. | 10-01-2009 |
20100021498 | LIVE, ATTENUATED PNEUMOCOCCAL VACCINE - This invention relates to a live mutated strain of | 01-28-2010 |
20100034850 | VACCINE - The standard dose of polio vaccines contains 40 D-antigen units of inactivated poliovirus type 1 (Mahoney), 8 D-antigen units of inactivated poliovirus type 2 (MEF-1), and 32 D-antigens units of inactivated poliovirus type 3 (Saukett). The present invention teaches that reduced doses of inactivated poliovirus can maintain adequate or improved level of protection against polio. | 02-11-2010 |
20100062018 | MYCOPLASMA HYOPNEUMONIAE BACTERIN VACCINE - The invention provides an improved | 03-11-2010 |
20100111997 | Multi component vaccine containing clostridial and non-clostridial organisms in a low dose - Disclosed herein is a multicomponent low dose vaccine comprising a safe and immunogenically effective combination of a protective antigen component or components of clostridial organism, a protective antigen component of a non-clostridial organism and an adjuvant. | 05-06-2010 |
20100119549 | CHLAMYDIAL ANTIGENS AS REAGENTS FOR DIAGNOSIS AND TREATMENT OF CHLAMYDIAL INFECTION AND DISEASE - The present invention provides | 05-13-2010 |
20100172932 | USE OF ISLET GLUCOSE-6-PHOSPHATASE RELATED PROTEIN AS A DIAGNOSTIC TOOL AND THERAPEUTIC TARGET FOR AUTOIMMUNE DIABETES - A method and compositions for detecting autoimmunity to islet glucose-6-phosphatase related protein (IGRP). Detection of IGRP autoantibodies alone, and in combination with other molecules such as the 65-kDa form of glutamate decarboxylase (GAD | 07-08-2010 |
20100247566 | CHOLERA VACCINES - The methods and compositions of the present invention are directed to a vaccine against | 09-30-2010 |
20100247567 | COMPOSITION AND METHOD FOR CONTROLLING INTESTINAL PATHOGENIC ORGANISMS - An antigen composition for stimulating an immune response in an inoculated avian species to at least one intestinal pathogenic organism includes seven field strains of | 09-30-2010 |
20100322964 | BACTERIAL COMPOSITION AND ITS USE - The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of | 12-23-2010 |
20110059128 | VACCINE COMPOSITION FOR VACCINATING DOGS AGAINST CANINE INFECTIOUS RESPIRATORY DISEASE (CIRD) - A vaccine composition for vaccinating dogs comprising any one or more of (a) an agent capable of raising an immune response against | 03-10-2011 |
20110070261 | Combination Vaccines Against Mycobacterium SP. and Methods of Using the Same - The invention relates to a combination vaccine against | 03-24-2011 |
20110182934 | IMMUNE SYSTEM STIMULATING NUTRITION - Disclosed is a nutritional composition comprising a combination of non-digestible oligosaccharides and a product obtained by incubating an aqueous substrate by bifidobacteria and optionally a product obtained by incubating an aqueous substrate by | 07-28-2011 |
20110195087 | COMBINATION VACCINE WITH WHOLE CELL PERTUSSIS - The present invention relates to a combination vaccine comprising a mixture of antigens for protection against diseases such as diphtheria, tetanus, whole cell pertussis and polio. The present invention also relates to inclusion of one or more antigens in the said combination vaccine, for protection against infections caused by | 08-11-2011 |
20110217329 | Vaccine - The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to vaccines comprising a pneumococcal polysaccharide antigen, typically a pneumococcal polysaccharide conjugate antigen, formulated with a protein antigen form | 09-08-2011 |
20110274720 | CAPSULAR GRAM-POSITIVE BACTERIA BIOCONJUGATE VACCINES - The present invention encompasses a novel | 11-10-2011 |
20120100178 | Compositions And Methods For Treatment Of Microbial Infections - The present invention relates to methods and compositions for treatment of microbial infections and for the enhancement of resistance to infection. The invention comprises administration of an effective amount of a protein isolated from bacterial lysate compositions for the treatment of pathological conditions of microbial infections. The present invention can also be used to enhance the immune system to prevent infections by the administration of an effective amount of the compositions. | 04-26-2012 |
20120107349 | MULTIVALENT NANOEMULSION VACCINES - The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides methods of inducing an immune response against one or a plurality of pathogens (e.g., vaccinia virus, H5N1 influenza virus, | 05-03-2012 |
20120213816 | MYCOPLASMA HYOPNEUMONIAE BACTERIN VACCINE - The invention provides an improved | 08-23-2012 |
20120276140 | COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY - Methods for making and using therapeutic formulations of Proteosome-based immunoactive compositions are provided. The immunogenic compositions, which include Proteosomes and liposaccharides, may be used to elicit or enhance a nonspecific innate immune response to, for example, treat or prevent infectious disease. In addition, after activating the innate immune system, immunogenic compositions further containing an antigen may be used to elicit a specific adaptive immune response. Furthermore, provided are compositions capable of altering hyperreactive responses or inflammatory immune responses, such as allergic reactions. Such compositions may be used as a prophylactic, or in various clinical settings to treat or prevent infectious disease (such as parasite, fungal, bacterial or viral infections), or to alter inappropriate inflammatory immune responses (such as allergic reactions or asthma). | 11-01-2012 |
20130273101 | VACCINE FOR INDUCING AN IMPROVED IMMUNE REACTION - The present invention relates to a pharmaceutical vaccine composition comprising: (a) a pathogen-derived antigen selected from the group consisting of | 10-17-2013 |
20140093536 | Compositions And Methods For Treatment Of Microbial Infections - The present invention relates to methods and compositions for treatment of microbial infections and for the enhancement of resistance to infection. The invention comprises administration of an effective amount of a protein isolated from bacterial lysate compositions for the treatment of pathological conditions of microbial infections. The present invention can also be used to enhance the immune system to prevent infections by the administration of an effective amount of the compositions. | 04-03-2014 |
20140186393 | IMMUNOGENIC COMPOSITION COMPRISING MYCOPLASMA ANTIGENS - The present invention relates to an immunogenic composition comprising: a) one or more antigen of | 07-03-2014 |
20140186394 | METHOD OF MAKING A MYCOPLASMA VACCINE - The present invention relates to a method for the preparation of an immunogenic composition for the treatment and/or prophylaxis of | 07-03-2014 |
20150050318 | MULTIVALENT NANOEMULSION VACCINES - The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides methods of inducing an immune response against one or a plurality of pathogens (e.g., vaccinia virus, H5N1 influenza virus, | 02-19-2015 |
20150132341 | FISH VACCINE - The present invention relates to novel compositions for medical use, particularly for use as vaccines. The present invention relies upon the dependence of the bacteria of the species | 05-14-2015 |
20150140034 | OIL-BASED ADJUVANTS - The instant invention provides various formulations comprising combinations of immunostimulating oligonucleotides, polycationic carriers, sterols, saponins, quaternary amines, TLR-3 agonists, glycolipids, and MPL-A or analogs thereof in oil emulsions, use thereof in preparations of immunogenic compositions and vaccines, and use thereof in the treatment of animals. | 05-21-2015 |
20150335725 | VACCINE FOR INTRAUTERINE DISEASE - Provided are compositions and methods for use in prophylaxis of puerperal metritis and improving reproductive function of ruminants. The methods and compositions are for subcutaneous administration and are provided as veterinary compositions and as articles of manufacture. The veterinary composition can contain whole cells selected from whole cells of | 11-26-2015 |
20160038582 | VACCINES FOR THE PREVENTION OF INFECTIONS WITH BORDETELLA - A vaccine for the prevention of infections with | 02-11-2016 |
20160051657 | Vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias - The invention relates to vaccines for treating prostate inflammation and benign prostate hyperplasias (stages I and II) comprising | 02-25-2016 |
20160199477 | Attenuated Mannheimia haemolytica Vaccines and Methods of Making and Use | 07-14-2016 |